Search results
What Is Triple-Negative Breast Cancer?
Verywell Health via Yahoo News· 1 year agoTriple-negative breast cancer (TNBC) is a type of breast cancer that does not have hormone receptors. TNBC is diagnosed in 10% to 15% of all cases of...
Roche (RHHBY) Tecentriq Meets Adjuvant Liver Cancer Study Goal
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) phase III IMbrave050 study, evaluating Tecentriq plus Avastin for treating...
Roche (RHHBY) Tecentriq SC Receives Positive CHMP Opinion
Zacks via Yahoo Finance· 7 months agoRoche RHHBY announced that the European Medicines Agency’s Committee for Medicinal Products for...
Roche's (RHHBY) Tecentriq Subcutaneous Gets Approval in the EU
Zacks via Yahoo Finance· 5 months agoRoche RHHBY announced that the European Commission has granted marketing authorization to...
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Zacks via Yahoo Finance· 6 months agoRoche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone...
Roche (RHHBY) Announces Data on Tecentriq Combo for HCC
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) new data from the late-stage IMbrave050 study reveals that the combination of...
Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
Benzinga via Yahoo Finance· 1 year agoGenentech, a unit of Roche Holdings AG (OTC: RHHBY), announced that the Phase 3 IMbrave050 study met...
Oncolytics (ONCY) Up on Lead Drug Securing 2nd FDA Fast Track Tag
Zacks via Yahoo Finance· 2 years agoOncolytics Biotech (ONCY) receives a fast-track designation from the FDA for pelareorep combined...
Roche (RHHBY) 1H Revenues, Earnings Down on Lower COVID-19 Test Sales
Zacks via Yahoo Finance· 11 months agoRoche Holding AG’s RHHBY performance in the first half was average, as COVID-19 product related...
Sonnet (SONN) Up as Ovarian Cancer Drug Enters Clinical Study
Zacks via Yahoo Finance· 10 months agoSonnet (SONN) receives FDA clearance to begin clinical development for its combination therapy of...